The Patent Finder

Terms ending in 2029

Pluri Biotech Ltd.

Every in-force patent on Pluri Biotech Ltd.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,517,248Adherent Cells from Adipose or Placenta Tissues and Use Thereof in Therapy
In force
 · Low confidence
Pluri Biotech Ltd.In forceLow confidence
US 8,524,496Adherent Cells from Placenta Tissue and Use Thereof in Therapy
In force
 · High confidence
Pluri Biotech Ltd.In forceHigh confidence
US 9,758,762Perfusion Bioreactor for Culturing CD200- Placenta Adherent Cells
In force
 · High confidence
Pluri Biotech Ltd.In forceHigh confidence
US 8,529,888Adherent Cells from Adipose or Placenta Tissues and Use Thereof in Therapy
In force
 · High confidence
Pluri Biotech Ltd.In forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited